News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,312 Results
Type
Article (13715)
Company Profile (101)
Press Release (250496)
Section
Business (88014)
Career Advice (465)
Deals (15341)
Drug Delivery (66)
Drug Development (36581)
Employer Resources (49)
FDA (6284)
Job Trends (6193)
News (150159)
Policy (14024)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Pharm Country Standard (1)
Academia (438)
Adcomms (6)
Allergies (28)
Alliances (23203)
ALS (32)
Alzheimer's disease (377)
Antibody-drug conjugate (ADC) (33)
Approvals (6307)
Artificial intelligence (94)
Autoimmune disease (4)
Automation (3)
Bankruptcy (146)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (49)
Biotechnology (40)
Bladder cancer (17)
Brain cancer (14)
Breast cancer (70)
Cancer (523)
Cardiovascular disease (55)
Career advice (406)
Career pathing (10)
CAR-T (17)
Cell therapy (74)
Cervical cancer (4)
Clinical research (30769)
Collaboration (289)
Compensation (119)
Complete response letters (16)
COVID-19 (754)
CRISPR (18)
C-suite (100)
Cystic fibrosis (35)
Data (526)
Denatured (15)
Depression (9)
Diabetes (70)
Diagnostics (1310)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (51)
Drug pricing (62)
Drug shortages (12)
Duchenne muscular dystrophy (26)
Earnings (31882)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37255)
Executive appointments (325)
FDA (6621)
Featured Employer (21)
Friedreich's ataxia (2)
Funding (182)
Gene editing (34)
Generative AI (8)
Gene therapy (90)
GLP-1 (325)
Government (1282)
Grass and pollen (2)
Guidances (15)
Healthcare (3557)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (26)
Indications (10)
Infectious disease (784)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (35)
Interviews (59)
IPO (5870)
IRA (29)
Job creations (2050)
Job search strategy (372)
Kidney cancer (6)
Labor market (7)
Layoffs (175)
Leadership (3)
Legal (3428)
Liver cancer (18)
Lung cancer (71)
Lymphoma (45)
Machine learning (1)
Management (16)
Manufacturing (128)
MASH (28)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9624)
Metabolic disorders (223)
Multiple sclerosis (16)
NASH (14)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (529)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (622)
Now hiring (7)
Obesity (127)
Opinion (116)
Ovarian cancer (18)
Pain (45)
Pancreatic cancer (13)
Parkinson's disease (39)
Partnered (5)
Patents (92)
Patient recruitment (26)
Peanut (9)
People (28782)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8009)
Phase II (13015)
Phase III (11679)
Pipeline (307)
Podcasts (44)
Policy (56)
Postmarket research (1401)
Preclinical (3191)
Press Release (25)
Prostate cancer (40)
Psychedelics (8)
Radiopharmaceuticals (118)
Rare diseases (148)
Real estate (2632)
Recruiting (17)
Regulatory (10024)
Reports (13)
Research institute (563)
Resumes & cover letters (55)
RSV (6)
Schizophrenia (31)
Series A (32)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (624)
Special edition (5)
Sponsored (6)
Startups (1626)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6259)
Vaccines (137)
Venture capitalists (13)
Webinars (10)
Weight loss (90)
Women's health (8)
Worklife (3)
Date
Today (60)
Last 7 days (266)
Last 30 days (1117)
Last 365 days (12340)
2025 (2170)
2024 (12500)
2023 (14248)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11714)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (47)
Arkansas (3)
Asia (20016)
Australia (2596)
California (1499)
Canada (814)
China (195)
Colorado (61)
Connecticut (62)
Delaware (49)
Europe (39229)
Florida (267)
Georgia (34)
Idaho (9)
Illinois (167)
India (11)
Indiana (121)
Iowa (1)
Japan (76)
Kansas (54)
Kentucky (12)
Maine (2)
Maryland (231)
Massachusetts (1285)
Michigan (27)
Minnesota (82)
Missouri (22)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (643)
New Mexico (7)
New York (427)
North Carolina (357)
North Dakota (2)
Northern California (622)
Ohio (43)
Oklahoma (4)
Oregon (16)
Pennsylvania (375)
Puerto Rico (5)
Rhode Island (5)
South America (500)
South Carolina (2)
Southern California (624)
Tennessee (29)
Texas (198)
Utah (32)
Virginia (65)
Washington D.C. (29)
Washington State (101)
Wisconsin (12)
264,312 Results for "aquavit pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
WIPO Publishes Aquavit’s Methods for Delivering Bioactive Compositions and Formulations to the Skin
Aquavit Pharmaceuticals, Inc. announced that the company’s technology patent for “Methods for Delivering Bioactive Compositions and Formulations Using Microchannel Delivery Device” has been approved for publishing by the World Intellectual Property Organization.
March 23, 2023
·
3 min read
Pharm Country
Aquavit Files Investigational New Drug Application for its Flagship Intradermal Injection of Botulinum Toxin
Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum toxin applications, announced today that it has filed an Investigational New Drug Application with the FDA for its flagship intradermal injection of botulinum toxin, Dermatox™ (aqubotulinumtoxinA).
April 28, 2023
·
2 min read
Policy
Aquavit Receives FDA Clearance for Two INDs to Initiate Clinical Trials With Its Botulinum Toxin
Aquavit Holdings announced that it has received FDA clearance to initiate clinical trials for DTX-023 and DTX-024, following its submission of Investigational New Drug Applications.
April 29, 2023
·
2 min read
Pharm Country
Aquavit Files Additional IND for DTX-024, a New Botulinum Toxin With Microchannel Technology™ for Palmar Hyperhidrosis
Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar hyperhidrosis using its patented microchannel technology™.
March 18, 2023
·
3 min read
Business
Aquavit Pharmaceuticals, Inc. Names Timothy Sherwood Chief Operating Officer
Aquavit Pharmaceuticals, Inc. announced that it has appointed Senior Vice President Timothy Sherwood as Chief Operating Officer.
May 17, 2022
·
1 min read
Policy
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
Aquavit Pharmaceuticals, Inc. announced that it has submitted its IND package for a new botulinum toxin to the FDA for approval.
March 24, 2022
·
2 min read
Policy
Aquavit Files Two IND’s For Its Botulinum Toxin With FDA
Announces its IND Submissions to FDA for Aquatox™ at the Annual American Academy of Dermatology 2023
March 17, 2023
·
3 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Pharm Country
Aquavit’s AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO
Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, recently announced that the company received a notice of allowance through the USPTO’s Fast-Track Prioritized Examination Pilot Program (PEPP) for the application of the company’s proprietary technology for self-injectable Covid 19 vaccination (AQV-1122.)
September 1, 2021
·
2 min read
Policy
Aquavit Pharmaceuticals, Inc. Wins Default Judgement Against Counterfeiter
Aquavit Pharmaceuticals, Inc. (“Aquavit”) won a default judgement against counterfeiter in the United States District Court for the Southern District of New York in a civil action against Global Medi Products, a South Korean company.
September 8, 2020
·
2 min read
1 of 26,432
Next